Grown Rogue International (GRUSF) Enterprise Value (QoQ) (2009 - 2026)
Grown Rogue International (GRUSF) Enterprise Value (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 86.26 Mn | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.68% |
| Dec 31, 2025 | 100.00% |
| Sep 30, 2025 | 100.00% |
| Jun 30, 2025 | -123,375,120,452,987.59% |
| Mar 31, 2025 | -335.55% |
| Dec 31, 2024 | 48.81% |
| Sep 30, 2024 | 28.22% |
| Jun 30, 2024 | 12.75% |
| Mar 31, 2024 | -26.27% |
| Oct 31, 2023 | 12.68% |
| Jul 31, 2023 | -110.71% |
| Apr 30, 2023 | -272.91% |
| Jan 31, 2023 | -140.31% |
| Jan 31, 2022 | -197.05% |
| Oct 31, 2021 | 627.05% |
| Jul 31, 2021 | 87.63% |
| Apr 30, 2021 | -88.99% |
| Jan 31, 2021 | -271.02% |
| Oct 31, 2020 | 57.15% |
| Jul 31, 2020 | 5.00% |